Search
  • Biohaven Pharmaceuticals

Changing People's Lives

Clinical Trials can change people's lives by helping researchers develop new medications to some of the most debilitating diseases. Listen to 12-year old Elyanna's story of her experience participating in a pediatric migraine clinical trial.


Biohaven Pharmaceuticals is studying an investigational drug, to potentially treat migraines in the pediatric population. If you or your child, between 6 and 17 years of age, suffer from migraine for at least 6 months you may qualify. Learn more about our pediatric migraine study.